Daniel T Robinson1, Michael Caplan2, Susan E Carlson3, Rachel Yoder3, Karna Murthy1, Brandy Frost2. 1. Ann & Robert H. Lurie Children's Hospital of Chicago and Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 2. Department of Pediatrics, NorthShore University HealthSystem, Pritzker School of Medicine, University of Chicago, Evanston, Illinois. 3. Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, Kansas.
Abstract
BACKGROUND: Extremely-low-birth-weight (ELBW) infants accrue large deficits in docosahexaenoic acid (DHA) and arachidonic acid (ARA) and require improved supplementation strategies. We hypothesized that once daily DHA+ARA drops applied to buccal mucosa will increase blood levels. METHODS:Thirty ELBW infants were randomized to receive DHA 20 mg/kg/d + ARA 40 or 60 mg/kg/d + ARA 120 mg/kg/d or placebo within 72 h of age for 8 wk duration. Red blood cell phospholipid levels of DHA (primary) and ARA (secondary) were measured at 2 and 8 wk of age. RESULTS:Twenty-eight survivors with a median birth weight of 806 g completed dosing and sampling. Red blood cell levels were similar between the three groups at 2 wk (DHA: 4.62 wt% (interquartile range (IQR) 4.1-5.5) for all, P = 0.29 between groups; ARA: 21.1 wt% (IQR 18.78-22.6) for all, P = 0.41 between groups) and 8 wk (DHA: 6.0 wt% (IQR 5.1-7.1) for all, P = 0.57 between groups; ARA: 20.1 wt% (IQR 18.3-23.1) for all, P = 0.63 between groups). DHA in all infants showed a median increase of 31% from 2 to 8 wk (P < 0.04). ARA levels did not significantly change over time (P > 0.6). CONCLUSION:Daily buccal DHA and ARA supplements did not affect fatty acid levels in ELBW infants.
RCT Entities:
BACKGROUND: Extremely-low-birth-weight (ELBW) infants accrue large deficits in docosahexaenoic acid (DHA) and arachidonic acid (ARA) and require improved supplementation strategies. We hypothesized that once daily DHA+ARA drops applied to buccal mucosa will increase blood levels. METHODS: Thirty ELBW infants were randomized to receive DHA 20 mg/kg/d + ARA 40 or 60 mg/kg/d + ARA 120 mg/kg/d or placebo within 72 h of age for 8 wk duration. Red blood cell phospholipid levels of DHA (primary) and ARA (secondary) were measured at 2 and 8 wk of age. RESULTS: Twenty-eight survivors with a median birth weight of 806 g completed dosing and sampling. Red blood cell levels were similar between the three groups at 2 wk (DHA: 4.62 wt% (interquartile range (IQR) 4.1-5.5) for all, P = 0.29 between groups; ARA: 21.1 wt% (IQR 18.78-22.6) for all, P = 0.41 between groups) and 8 wk (DHA: 6.0 wt% (IQR 5.1-7.1) for all, P = 0.57 between groups; ARA: 20.1 wt% (IQR 18.3-23.1) for all, P = 0.63 between groups). DHA in all infants showed a median increase of 31% from 2 to 8 wk (P < 0.04). ARA levels did not significantly change over time (P > 0.6). CONCLUSION: Daily buccal DHA and ARA supplements did not affect fatty acid levels in ELBW infants.
Authors: Maria Makrides; Robert A Gibson; Andrew J McPhee; Carmel T Collins; Peter G Davis; Lex W Doyle; Karen Simmer; Paul B Colditz; Scott Morris; Lisa G Smithers; Kristyn Willson; Philip Ryan Journal: JAMA Date: 2009-01-14 Impact factor: 56.272
Authors: J Thomas Brenna; Behzad Varamini; Robert G Jensen; Deborah A Diersen-Schade; Julia A Boettcher; Linda M Arterburn Journal: Am J Clin Nutr Date: 2007-06 Impact factor: 7.045
Authors: Leeann R Pavlek; Brian K Rivera; Charles V Smith; Joanie Randle; Cory Hanlon; Kristi Small; Edward F Bell; Matthew A Rysavy; Sara Conroy; Carl H Backes Journal: J Pediatr Date: 2021-04-21 Impact factor: 6.314
Authors: Patricia Álvarez; David Ramiro-Cortijo; María Teresa Montes; Bárbara Moreno; María V Calvo; Ge Liu; Ana Esteban Romero; Marta Ybarra; Malaika Cordeiro; Marina Clambor Murube; Eva Valverde; Aurora Sánchez-Pacheco; Javier Fontecha; Robert Gibson; Miguel Saenz de Pipaon Journal: Front Pediatr Date: 2022-08-25 Impact factor: 3.569